Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Pigment Cell & Melanoma Research|October 19, 2011
CSPG4, a potential therapeutic target, facilitates malignant progression of melanomaMatthew A Price, Leah E Colvin Wanshura, Jianbo Yang, et al.
The Journal of Biological Chemistry|March 30, 2007
The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cellsSara R Hamilton, Shireen F Fard, Frouz F Paiwand, et al.
Cancer Research|September 10, 2009
Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transitionJianbo Yang, Matthew A Price, Gui Yuan Li, et al.
Melanoma Research|May 30, 2019
Chondroitin sulfate proteoglycan 4 enhanced melanoma motility and growth requires a cysteine in the core protein transmembrane domainJianbo Yang, Matthew A Price, Leah E C Wanshura, et al.
The Journal of Biological Chemistry|June 19, 2010
RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1/ERK1/2 activityCornelia Tolg, Sara R Hamilton, Lyndsey Morningstar, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|February 25, 2017
Hyaluronan modulates growth factor induced mammary gland branching in a size dependent mannerCornelia Tolg, Han Yuan, Sarah M Flynn, et al.
Plos One|December 2, 2015
Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 DiabetesNathalie Assayag-Asherie, Dror Sever, Marika Bogdani, et al.
Breast Cancer Research : BCR|June 22, 2023
RHAMM regulates MMTV-PyMT-induced lung metastasis by connecting STING-dependent DNA damage sensing to interferon/STAT1 pro-apoptosis signalingCornelia Tolg, Maja Milojevic, Freda W Qi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2004
RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancyShlomo Nedvetzki, Erez Gonen, Nathalie Assayag, et al.
The American Journal of Pathology|August 15, 2012
A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin woundsCornelia Tolg, Sara R Hamilton, Ewa Zalinska, et al.
Pageof 5